Identifiers
- 510(k) Number
- K201933 FDA 510(k)
- FDA Product Code
- KPS FDA 510(k)
Classification
- Device Class
- Class II FDA 510(k)
- Legislation / Framework
- 21 CFR Part 892.1200 FDA 510(k)
- Regulation Number
- 892.1200 FDA 510(k)
- Advisory Committee
- Radiology FDA 510(k)
- FDA Decision
- SESE Substantially Equivalent FDA 510(k)
The ImagenSPECT 3.0 is a computed emission tomography system designed for single-photon emission computed tomography (SPECT) imaging. It employs advanced iterative reconstruction and system modeling to enhance image quality while optimizing scan parameters, such as reducing scan time or radiotracer dose.
This device is intended for use in radiology settings and has received FDA 510(k) clearance under the Special 510(k) pathway. It is supplied as a reusable system with multiple registration numbers and FEI numbers listed under the regulation 892.1200. The device is not described as sterile or single-use, and no MRI safety classification is provided in the specifications.
Frequently asked questions
What types of medical imaging procedures is the ImagenSPECT 3.0 designed to perform, and how does it improve image quality compared to traditional methods?
The ImagenSPECT 3.0 is specifically designed for single-photon emission computed tomography (SPECT) imaging, a nuclear medicine technique used to visualize blood flow and tissue function in organs like the heart, brain, or bones. It enhances image quality through advanced iterative reconstruction and system modeling, which optimize scan parameters such as reducing scan time or lowering the required radiotracer dose. This makes it more efficient and potentially less burdensome for patients compared to conventional SPECT systems.
Is the ImagenSPECT 3.0 a single-use or reusable device, and what does this mean for maintenance and operational workflows?
The ImagenSPECT 3.0 is a reusable system, meaning it is designed for repeated use across multiple patients. This implies that your facility will need to establish protocols for cleaning, calibration, and maintenance to ensure consistent performance and compliance with regulatory standards. Reusability also allows for cost savings over time but requires dedicated resources for upkeep.
What regulatory pathway was followed for the FDA clearance of the ImagenSPECT 3.0, and what does this mean for its intended use?
The ImagenSPECT 3.0 received FDA clearance under the Special 510(k) pathway, which is used for devices that are substantially equivalent to a predicate device already on the market. This clearance confirms that the device meets FDA standards for safety and effectiveness as a computed emission tomography system for SPECT imaging, specifically in radiology settings. The pathway does not alter the clinical indications—those are determined by the device’s design and intended use, not the regulatory route.
How many unique registration numbers or FEI numbers are associated with the ImagenSPECT 3.0, and why might this matter for inventory or compliance?
The ImagenSPECT 3.0 is linked to 37 unique FEI numbers and 37 registration numbers under FDA regulation 892.1200. These identifiers are used for tracking, reporting, and compliance purposes, such as inventory management, recall coordination, or regulatory audits. Having multiple numbers may reflect variations in system configurations, accessories, or software versions, so your facility should verify which specific FEI/registration numbers apply to your purchased unit for accurate record-keeping.
Does the ImagenSPECT 3.0 require any special handling or storage conditions, and what should I consider for its long-term use?
The provided data does not specify any special storage conditions (e.g., temperature, humidity, or shielding requirements) for the ImagenSPECT 3.0. However, as a reusable medical device, it should be stored in a clean, dry environment protected from physical damage or electromagnetic interference. Since it is not described as sterile or single-use, your facility’s infection control protocols for reusable imaging equipment (e.g., cleaning agents, sterilization cycles) will apply. Always refer to the manufacturer’s instructions for maintenance and operational guidelines.
This description and any FAQs above were generated automatically from registry data and have not been verified by the manufacturer or by deviCERTS. Always check the official registry entry and the manufacturer's instructions for use before relying on them. Sources consulted: ImagenSPECT 3.0 | Cardiovascular Imaging Technologies, Cardiovascular Imaging Technologies | PET, K201933 - ImagenSPECT 3.0 - Radiology
Authorization Coverage (1 country)
Regulatory Authorizations
FDA_510K
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA 510(k) | United States | FDA_510K | K201933 | Class II | Active |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Cardiovascular Imaging Technologies
Sources (1)
- FDA 510(k) K201933 24 fields · synced Sep 19, 2026